retatrutide trial results Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Retatrutide NEW Phase 3 Clinical

Triglycerides decreased by 35-40%

If the same step fails twice, that dose level may be your minimum effective dose, and continuing the taper may not be appropriate

We want to hear it!

Beyond GLP-1: The Other Innovations While GLP-1 agonists have set a new benchmark, the quest for even more effective, tolerable, and accessible obesity treatments continues

By week 36, this weight loss effect was even more pronounced, increasing from 9.4% to 14.7%, while the placebo group saw a reduction of only 2.3%

Each success story and positive review serves as a testament to the effectiveness of Shapelys weight loss program and the potential for anyone to make positive changes in their lives with the right guidance and support